Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

Arthritis and Rheumatism

Volumn 40, Issue 2, 1997, Pages 249-260

  Joosten, Leo A B ^a   Lubberts, Erik ^a   Durez, Patrick ^b   Helsen, Monique M A ^a   Jacobs, Marike J M ^a   Goldman, Michel ^b   Van den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; IMMUNOTHERAPY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE DISEASES; CATTLE; COLLAGEN; DISEASE MODELS, ANIMAL; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-4; KNEE JOINT; MALE; MICE; MICE, INBRED DBA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031059255     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400209     Document Type: Article

References (58)

1. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2095, 1989
2. Moore KW, O'Garra A, De Waal-Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
3. 2. Proc Natl Acad Sci U S A 86:3803-3807, 1989
4. Vannier E, Miller LC, Dinarello CA: Coordinated anti-inflammatory effects of interleukin-4: IL-4 suppresses IL-1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A 89:4076-4080, 1992
5. De Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
6. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits the cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991
7. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. J Biol Chem 270:9558-9563, 1995
8. Collota F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Dower SK, Sims JE, Mantovani A: Interleukin-1 type II receptor: as a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475, 1993
9. Cope AP, Gibbons DL, Aderka D: Differential regulation of tumor necrosis factor receptors (TNF-R) by IL-4: upregulation of p55 and p75 TNF-R on synovial joint mononuclear cells. Cytokine 3:205-208, 1993
10. Jenkins JK, Malyak M, Arend WP: The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res 13:47-54, 1994
11. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S: Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179:1695-1699, 1994
12. Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995
13. Bucala R, Ritchlin C, Winchester R, Cerami A: Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173:569-574, 1991
14. Elliot MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen J, Leeb B, Breedveld EC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
15. Rankin ECC, Choy EHS, Kassimos D, Kingsley GH, Sopwith AM, Isenberg DA, Panayi GS: The therapeutic effects of an engineered human anti-tumour necrosis factor α antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol 34:334-342, 1995
16. Trentham DE, Townes AS, Rang AH: Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146:857-868, 1977
17. Courtenay JS, Dallman MJ, Dayan AB, Martin A, Mosedale B: Immunization against heterologous type II collagen-induced arthritis in mice. Nature 2843:666-668, 1980
18. Stuart JM, Townes AS, Kang AH: Nature and specificity of immune responses to collagen in type II collagen-induced arthritis in mice. J Clin Invest 69:673-683, 1982
19. Williams RO, Feldmann M, Maini RN: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 89:9784-9788, 1992
20. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA: Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Natl Acad Sci U S A 89:7375-7379, 1992
21. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB: Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra. Arthritis Rheum 39:797-809, 1996
22. Van den Berg WB, Joosten LAB, Helsen MMA, van de Loo AJJ: Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 11:237-243, 1994
23. Joosten LAB, Helsen MMA, van den Berg WB: Accelerated onset of collagen-induced arthritis by remote inflammation. Clin Exp Immunol 97:204-211, 1994
24. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davies LS, Fujita K, Lipsky PE: Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 38:96-104, 1995
25. Katsikis P, Chu CO, Brennan FM, Maini RN, Feldmann M: Immunoregulatory role of interleukin-10 (IL-10) in rheumatoid arthritis. J Exp Med 179:1517-1527, 1994
26. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P: Balance of IL-1 receptor antagonist/ IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154:1432-1439, 1995
27. Gerard D, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550, 1993
28. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA: Protective effect of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 151:5666-5672, 1993
29. Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM: Suppression of monocyte function and differential regulation of IL-1 and IL-1Ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151:4344-4351, 1993
30. Kasama T, Stricter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL: Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95:2868-2876, 1995
31. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M: Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39:495-503, 1996
32. Pradier O, Gerard C, Delvaux A, Lybin M, Abramowicz D, Capel P, Velu T, Goldman G: Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700-2703, 1993
33. Hu-Li J, Ohara J, Watson C, Tsang W, Paul WE: Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol 142:800-807, 1989
34. Schlaak JF, Schmit E, Huls C, Meyer zum Buschenfelde KH, Fleischer B: A sensitive and specific bioassay for the detection of human interleukin-10. J Immunol Methods 168:49-54, 1994
35. Jacobs MJM, van den Hoek AEM, van Lent PLEM, van de Loo AJJ, van de Putte LBA, van den berg WB: Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology 83:390-396, 1994
36. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin-10 antibodies delays the onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310, 1994
37. Miller EJ, Rhodes RK: Preparation and characterization of the different types of collagen. Methods Enzymol 82:33-65, 1982
38. Caccese RG, Zimmerman JL, Carlson RP: Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators Inflamm 1:273-279, 1992
39. Van den Berg WB, Joosten LAB, van de Putte LBA: Electrical charge of the antigen determines intraarticular handling and chronicity of arthritis in mice. J Clin Invest 74:1850-1859, 1982
40. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
41. Nasrin N, Colanil E, Denaro M, Kong XF, Kang I, Alexander M: An insulin response element in the glyceraldehyde-3-phosphate dehydrogenase gene binds a nuclear protein induced by insulin in culturecfcells. Proc Natl Acad Sci USA 87:5273-5277, 1990
42. Montgomery RA, Dallman PS: Analysis of cytokine gene expres- sion during fetal thymic ontogeny using the poiymerase chain reaction. J Immunol 147:554-560, 1991
43. Chensue SW, Bienkowski M, Eessalu TE, Warmington K.S, Hershey SD, Lukacs NW, Kunkel SL: Endogenous IL-1 receptor antagonist protein (IRAP) regulates schistosome egg granuloma formation and the regional lymphoid response. J Immunol 151: 3654-3662, 1993
44. Murray LJ, Lee R, Martens C: In vivo cytokine expression in T-cell subset of the autoimmune MRL/MP-1pr/1pr mouse. Eur J Immunol 20:163-170, 1990
45. Wang AM, Doyle MV, Mark DF: Quantification of mRNA by the poiymerase chain reaction. Proc Natl Acad Sci U S A 86:9717-9721, 1989
46. Christen AJ, Mudgett JS, Orevillo CJ, Shen CF, Zheng H, Kostura M, Visco DM: Collagen-induced arthritis in the interleukin-1β knock-out mouse (abstract). Orthop Res Soc 21:169-29, 1996
47. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Soszynski D, Grabiec D, Trumbauer ME, Shaw A, Kostura MJ, Stevens K, Rosen H, North RJ, Chen HY, Tocci MJ, Kluger MJ, van der Ploeg LHT: Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity 3:9-19, 1995
48. Dechanet J, Taupin J, Chomarat P, Rissoan M, Moreau J, Banchereau J, Miossec P: Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur J Immunol 24:3222-3228, 1994
49. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ: Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 84:536-542, 1995
50. Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T, Yamashita N, Maruyama M, Kobayashi M: Interleukin-10 cooperates with interleukin-4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 22:2020-2026, 1995
51. Yen L, Augustine AJ, Lee P, Riviere LR, Sheldon A: Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol 22:1740-1746, 1995
52. Kuhn R, Lohler J, Rennick D, Rajewski K, Muller W: Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993
53. Berg DJ, Leach MW, Kuhn R, Rajewski K, Muller W, Davidson NJ, Rennick D: Interleukin-10 but not interleukin-4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182:99-108, 1995
54. Berg DJ, Kuhn R, Rajewski K, Muller W, Menon S, Davidson NJ, Grunig G, Rennick D: Interleukin-10 is a central regulator of the response to LPS on murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96:2339-2347, 1995
55. Connors M, Giese NA, Kulkarni AB, Firestone C, Morse HC III, Murphy BR: Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol 68:5321-5325, 1994
56. Salerno A, Dieli F, Sireci G, Bellavia A, Asherson GL: Interleukin-4 is a critical cytokine in contact sensitivity. Immunology 84:404-409, 1995
57. Dieli F, Asherson GL, Romano GC, Sireci G, Gervasi F, Salerno A: IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. J Immunol 152:2698-2704, 1994
58. Rosenbaum JT, Angell E: Paradoxical effects of IL-10 in endotoxin-induced uveitis. J Immunol 155:4090-4094, 1995